Atorfirst F Tablet is a dual lipid-lowering medication used to manage high cholesterol and triglyceride levels in patients at risk of heart disease, stroke, and related vascular conditions. It combines two well-established agents—Atorvastatin (a statin) and Fenofibrate (a fibrate)—that work through different mechanisms to provide comprehensive lipid control and protection against cardiovascular complications.

• Atorvastatin 10 MG: A potent HMG-CoA reductase inhibitor that decreases cholesterol synthesis in the liver. It lowers LDL (“bad” cholesterol) and triglycerides while improving HDL (“good” cholesterol).

• Fenofibrate 160 MG: Works by activating peroxisome proliferator-activated receptor-alpha (PPAR-α), which increases the breakdown of triglycerides and enhances HDL cholesterol.

This powerful combination is especially useful for treating mixed dyslipidemia—a condition characterized by elevated triglycerides and cholesterol levels that can accelerate plaque buildup in arteries. It helps reduce the risk of atherosclerosis, heart attack, and stroke by maintaining a healthy lipid balance.